CoreCap Advisors’s Phibro Animal Health PAHC Stock Holding History

CoreCap Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.25K	Buy	+35	New	+$1.23K	﹤0.01%	2621

Other funds holding PAHC

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

CoreCap Advisors's PAHC Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Phibro Animal Health (PAHC) in Q3 2026: 35 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #2621 among its holdings.

10 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

CoreCap Advisors held 35 shares of Phibro Animal Health worth $1.25K as of Q3 2026.
Phibro Animal Health was a new CoreCap Advisors position in Q3 2026.
Phibro Animal Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2621 holding.
10 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.